Abstract
Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory Marginal Zone Lymphoma: Initial Results of the MAGNOLIA (BGB-3111-214) Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have